Legal & General Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $3.58K | Hold |
|
|||||
2024
Q4 | $4.02K | Hold |
|
|||||
2024
Q3 | $12.7K | Hold |
|
|||||
2024
Q2 | $17.7K | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $41.8K | Sell |
|
|||||
2022
Q4 | $163K | Buy |
|
|||||
2022
Q3 | $162K | Sell |
|
|||||
2022
Q2 | $286K | Buy |
|
|||||
2022
Q1 | $577K | Hold |
|
|||||
2021
Q4 | $802K | Hold |
|
|||||
2021
Q3 | $1.15M | Buy |
|
|||||
2021
Q2 | $1.11M | Sell |
|
|||||
2021
Q1 | $1.15M | Buy |
|
|||||
2020
Q4 | $854K | Sell |
|
|||||
2020
Q3 | $1.12M | Buy |
|
|||||
2020
Q2 | $1.18M | Buy |
|
|||||
2020
Q1 | $159K | Sell |
|
|||||
2019
Q4 | $87K | Buy |
|
|||||
2019
Q3 | $52K | Buy |
|
|||||
2019
Q2 | $57K | Buy |
|
|||||
2019
Q1 | $60K | Buy |
|
|||||
2018
Q4 | $61K | Buy |
|
|||||
2018
Q3 | $72K | Hold |
|
|||||
2018
Q2 | $51K | Sell |
|
|||||
2018
Q1 | $70K | Sell |
|
|||||
2017
Q4 | $86K | Hold |
|
|||||
2017
Q3 | $132K | Buy |
|
|||||
2017
Q2 | $127K | Hold |
|
|||||
2017
Q1 | $106K | Sell |
|
|||||
2016
Q4 | $113K | Buy |
|
|||||
2016
Q3 | $71K | Sell |
|
|||||
2016
Q2 | $121K | Hold |
|
|||||
2016
Q1 | $119K | Buy |
|
|||||
2015
Q4 | $83K | Hold |
|
|||||
2015
Q3 | $70K | Buy |
|
|||||
2015
Q2 | $88K | Buy |
|
|||||
2015
Q1 | $72K | Hold |
|
|||||
2014
Q4 | $82K | Hold |
|
|||||
2014
Q3 | $87K | Buy |
|